EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Fiber‐Specific White Matter Alterations in Parkinson's Disease Patients with GBA Gene Mutations

Christina Andica iD, Koji Kamagata iD, Wataru Uchida iD, Yuya Saito, Kaito Takabayashi iD, Akifumi Hagiwara iD, Haruka Takeshige-Amano iD, Taku Hatano iD, Nobutaka Hattori iD, Shigeki Aoki iD

Movement Disorders · 2023-11 · 38 (11) · 2019-2030

DOI: 10.1002/mds.29578 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, online erschienen am 22.08.2023. Verfasst von Christina Andica und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Juntendo University Graduate School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Parkinson Disease, White Matter. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Grant-in-Aid for Special Research in Subsidies for ordinary expenses of private schools from The Promotion and Mutual Aid Corporation for Private Schools of Ja…, Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with Parkinson's disease (PD) carrying GBA gene mutations (GBA‐PD) have a more aggressive disease course than those with idiopathic PD (iPD).

Objective

The objective of this study was to investigate fiber‐specific white matter (WM) differences in nonmedicated patients with early‐stage GBA‐PD and iPD using fixel‐based analysis, a novel technique to assess tract‐specific WM microstructural and macrostructural features comprehensively.

Methods

Fixel‐based metrics, including microstructural fiber density (FD), macrostructural fiber‐bundle cross section (FC), and a combination of FD and FC (FDC), were compared among 30 healthy control subjects, 16 patients with GBA‐PD, and 35 patients with iPD. Associations between FDC and clinical evaluations were also explored using multiple linear regression analyses.

Results

Patients with GBA‐PD showed significantly lower FD in the fornix and superior longitudinal fasciculus than healthy control subjects, and lower FC in the corticospinal tract (CST) and lower FDC in the CST, middle cerebellar peduncle, and striatal‐thalamo‐cortical pathways than patients with iPD. Contrarily, patients with iPD showed significantly higher FC and FDC in the CST and striatal‐thalamo‐cortical pathways than healthy control subjects. In addition, lower FDC in patients with GBA‐PD was associated with reduced glucocerebrosidase enzyme activity, lower cerebrospinal fluid total α‐synuclein levels, lower Montreal Cognitive Assessment scores, lower striatal binding ratio, and higher Unified Parkinson's Disease Rating Scale Part III scores.

Conclusions

We report reduced fiber‐specific WM density and bundle cross‐sectional size in patients with GBA‐PD, suggesting neurodegeneration linked to glucocerebrosidase deficiency, α‐synuclein accumulation, and poorer cognition and motor functions. Conversely, patients with iPD showed increased fiber bundle size, likely because of WM reorganization. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseWhite MatterHumansalpha-SynucleinCross-Sectional StudiesGlucosylceramidaseMutation

Stichwörter der Autor:innen

GBA gene mutationsParkinson's diseasefixel-based analysisneurodegenerationneuroplasticity

Substanzen

alpha-SynucleinGlucosylceramidase

Autor:innen und Institutionen

  • Department of Radiology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Faculty of Health Data Science, Juntendo University, Chiba, Japan.
  • Department of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan.

ORCID-Profile: Christina Andica, Koji Kamagata, Wataru Uchida, Kaito Takabayashi, Akifumi Hagiwara, Haruka Takeshige-Amano, Taku Hatano, Nobutaka Hattori, Shigeki Aoki

Förderung

  • Grant-in-Aid for Special Research in Subsidies for ordinary expenses of private schools from The Promotion and Mutual Aid Corporation for Private Schools of Ja…
  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science
  • PPMI - a public-private partnership - is funded by the Michael J. Fox Foundation for Parkinson's Research funding partners 4D Pharma, Abbvie, Acurex Therapeuti…
  • The Brain/MINDS Beyond program of the Japan Agency for Medical Research and Development
  • The Juntendo Research Branding Project
  • The Project for Training Experts in Statistical Sciences

Zitieren

APA

Andica, C., Kamagata, K., Uchida, W., Saito, Y., Takabayashi, K., Hagiwara, A., Takeshige-Amano, H., Hatano, T., Hattori, N., & Aoki, S. (2023). Fiber‐Specific White Matter Alterations in Parkinson's Disease Patients with GBA Gene Mutations. Movement Disorders, 38(11), 2019-2030. https://doi.org/10.1002/mds.29578

Vancouver

Andica C, Kamagata K, Uchida W, Saito Y, Takabayashi K, Hagiwara A, et al. Fiber‐Specific White Matter Alterations in Parkinson's Disease Patients with GBA Gene Mutations. Movement Disorders. 2023;38(11):2019-2030. doi:10.1002/mds.29578

BibTeX
@article{Andica2023,
  author = {Andica, Christina and Kamagata, Koji and Uchida, Wataru and Saito, Yuya and Takabayashi, Kaito and Hagiwara, Akifumi and Takeshige-Amano, Haruka and Hatano, Taku and Hattori, Nobutaka and Aoki, Shigeki},
  title = {Fiber‐Specific White Matter Alterations in Parkinson's Disease Patients with GBA Gene Mutations},
  journal = {Movement Disorders},
  year = {2023},
  volume = {38},
  number = {11},
  pages = {2019--2030},
  doi = {10.1002/mds.29578}
}
Kostenlos starten →